Clinical Trials Directory

Trials / Completed

CompletedNCT06661889

OM2 Low Saturation Verification

Low Saturation Verification of Investigational Pulse Oximetry Devices in Adult Volunteers

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

Detailed description

To verify the SpO2 and pulse rate accuracy in comparison to a reference standard blood measurements. To achieve paired observations of SpO2 and SaO2 values over the specified SpO2 accuracy range of the prototype pulse oximeter on a group of healthy adult volunteers. The fraction of inspired oxygen (FiO2) delivered to test subjects is varied to achieve a series of targeted steadystate saturation periods. In this study, the investigational pulse oximetry PCBA system saturation measurements will be compared to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from a diverse pool of healthy human subjects.

Conditions

Timeline

Start date
2024-11-18
Primary completion
2025-02-27
Completion
2025-05-27
First posted
2024-10-28
Last updated
2025-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06661889. Inclusion in this directory is not an endorsement.

OM2 Low Saturation Verification (NCT06661889) · Clinical Trials Directory